Donepezil
De LibreFind
| Advanced search |
- About 4 results found and you can help!
Donepezil, marketed under the trade name Aricept by its developer Eisai and partner Pfizer, is a centrally acting reversible acetylcholinesterase inhibitor. Its main therapeutic use is in the palliative treatment of mild to moderate Alzheimer's disease. Common side effects include gastrointestinal upset. It has an oral bioavailability of 100% and easily crosses the blood–brain barrier. Because it has a half-life of about 70 hours, it can be taken once a day.
- See also: Wikipedia
- Related: Add a related term
| Official Aricept product site Official Aricept product site www.aricept.com - Web |
| Aricept entry at Drugs.com Aricept entry at Drugs.com www.drugs.com/aricept.html - Web |
| 3D Molecular structure of Donepezil 3D Molecular structure of Donepezil proteopedia.org/wiki/index.php/Donepezil - Web |
Average relevance
| Donepezil bound to proteins Donepezil bound to proteins www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=E20 - Web |
